Crystalline forms of (9, 135s)-13- {4-[5-chloro-2-(4-chloro-1h,2,3- triazol- 1 -yl)phenyl] -6-oxo- 1,6-dihydropyrimidin- 1-yl}-3-(difluoromethyl)-9-methyl-3,4,7,15- tetraazatricyclo [ 12.3.1.0] octadeca- 1(18), 2(6), 4, 14, 16-pentaen-8-one

LT4132930TActive Publication Date: 2026-08-25BRISTOL MYERS SQUIBB CO +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
LT4132930P0
Authority / Receiving Office
LT · LT
Patent Type
Patents
Current Assignee / Owner
Priority Date
2021-04-09
Filing Date
2021-04-09
Publication Date
2026-08-25
Estimated Expiration
2041-04-09
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.